Scott B Kozak

Scott received a BS in Marketing from the University of Connecticut, School of Business, and earned an MBA in (International) Marketing from Georgia State University’s Kennesaw State University Michael J. Coles School of Business. Scott has over 30 years of experience in the pharmaceutical/life science industry and has held senior positions in marketing, brand management, business development, licensing & corporate development. He has helped companies partner assets, raise funds and go public. Over the past decade, Scott co-founded several companies including New Haven Pharmaceuticals, Prevention Pharmaceuticals and Rho Renewables. As part of his consulting business since 2008 which helps life science companies with fundraising, partnering and general business development he was most recently the Head of Business Development for Universal Sequencing Technology (UST), a next-generation DNA Sequencing company located in Boston. Additionally, he was Head of Licensing & Business Development for AlloMek, a New Haven, CT-based Rare Disease & Oncology company, founded by ex-Bayer scientists & backed by the CT-based venture capital group Connecticut Innovations. Scott has also worked with the UCONN Incubator company, Potentiometric Probes, a company that is marketing Voltage-Sensitive Dyes for cardiovascular & neurological drug discovery, to help them raise funds and find global distribution partners. In 2018, Scott became an Adjunct Professor at the University of Connecticut Graduate School of Business, Connecticut Center for Entrepreneurship & Innovation (CCEI). He is currently teaching Biomedical Entrepreneurship and in the Spring 2020 had oversight for a newly created course, Entrepreneurship Mentoring, an Independent Study opportunity for students trying to determine viability for their products & ideas. He is currently an Entrepreneur in Residence and Professor of Practice at CCEI. Since 2017, Scott has been a mentor to undergraduates in the UCONN School of Business as well as at CCEI, supporting several of their NSF iCorp funded courses and programs.